170 related articles for article (PubMed ID: 33091544)
1. High lifetime, but low current, prevalence of new psychotropic substances (NPS) use in German drug detoxification treatment young inpatients.
Scherbaum N; Seiffert F; Schifano F; Specka M; Bonnet U; Bender S
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Dec; 111():110144. PubMed ID: 33091544
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of psychiatric inpatients diagnosed with mental and behavioral disorders caused by psychoactive substances (F11-19 block), with a focus on NPS and psychiatric co-morbidities.
Engelgardt P; Krzyżanowski M; Piotrowski P; Borkowska-Sztachańska M; Wasilewska A; Kowalkowski T
Int J Occup Med Environ Health; 2020 Mar; 33(2):125-136. PubMed ID: 31942874
[TBL] [Abstract][Full Text] [Related]
3. Self-reported use of novel psychoactive substances in a US nationally representative survey: Prevalence, correlates, and a call for new survey methods to prevent underreporting.
Palamar JJ; Martins SS; Su MK; Ompad DC
Drug Alcohol Depend; 2015 Nov; 156():112-119. PubMed ID: 26377051
[TBL] [Abstract][Full Text] [Related]
4. Lifetime prevalence of novel psychoactive substances use among adults in the USA: Sociodemographic, mental health and illicit drug use correlates. Evidence from a population-based survey 2007-2014.
Neicun J; Yang JC; Shih H; Nadella P; van Kessel R; Negri A; Czabanowska K; Brayne C; Roman-Urrestarazu A
PLoS One; 2020; 15(10):e0241056. PubMed ID: 33125395
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of Novel Psychoactive Substance (NPS) Use in Patients Admitted to Drug Detoxification Treatment.
Specka M; Kuhlmann T; Sawazki J; Bonnet U; Steinert R; Cybulska-Rycicki M; Eich H; Zeiske B; Niedersteberg A; Schaaf L; Scherbaum N
Front Psychiatry; 2020; 11():569. PubMed ID: 32733288
[TBL] [Abstract][Full Text] [Related]
6. A systematic review of the effects of novel psychoactive substances 'legal highs' on people with severe mental illness.
Gray R; Bressington D; Hughes E; Ivanecka A
J Psychiatr Ment Health Nurs; 2016 Jun; 23(5):267-81. PubMed ID: 27037639
[TBL] [Abstract][Full Text] [Related]
7. Examination of Synthetic Cannabinoid and Cathinone Use among a Drug-Using Offender Sample, 2013-2015.
Smith KE; Bunting AM; Staton M; Walker R; Shalash S; Winston E; Pangburn K
J Psychoactive Drugs; 2017; 49(5):436-445. PubMed ID: 28813207
[TBL] [Abstract][Full Text] [Related]
8. New/emerging psychoactive substances and associated psychopathological consequences.
Schifano F; Napoletano F; Chiappini S; Guirguis A; Corkery JM; Bonaccorso S; Ricciardi A; Scherbaum N; Vento A
Psychol Med; 2021 Jan; 51(1):30-42. PubMed ID: 31327332
[TBL] [Abstract][Full Text] [Related]
9. New Psychoactive Substances (NPS) - a Challenge for the Addiction Treatment Services.
Scherbaum N; Schifano F; Bonnet U
Pharmacopsychiatry; 2017 May; 50(3):116-122. PubMed ID: 28444659
[TBL] [Abstract][Full Text] [Related]
10. New Psychoactive Substances and Suicidality: A Systematic Review of the Current Literature.
Chiappini S; Mosca A; Miuli A; Santovito MC; Orsolini L; Corkery JM; Guirguis A; Pettorruso M; Martinotti G; Di Giannantonio M; Schifano F
Medicina (Kaunas); 2021 Jun; 57(6):. PubMed ID: 34204131
[No Abstract] [Full Text] [Related]
11. Novel psychoactive substances-related presentations to the emergency departments of the European drug emergencies network plus (Euro-DEN plus) over the six-year period 2014-2019.
Crulli B; Dines AM; Blanco G; Giraudon I; Eyer F; Liechti ME; Miró Ò; Hovda KE; Heyerdahl F; Yates C; Vallersnes OM; Wood DM; Dargan PI;
Clin Toxicol (Phila); 2022 Dec; 60(12):1318-1327. PubMed ID: 36322684
[TBL] [Abstract][Full Text] [Related]
12. Novel psychoactive substances: use and knowledge among adolescents and young adults in urban and rural areas.
Martinotti G; Lupi M; Carlucci L; Cinosi E; Santacroce R; Acciavatti T; Chillemi E; Bonifaci L; Janiri L; Di Giannantonio M
Hum Psychopharmacol; 2015 Jul; 30(4):295-301. PubMed ID: 26216566
[TBL] [Abstract][Full Text] [Related]
13. Novel psychoactive substance and other drug use by young adults in Western australia.
Goggin LS; Gately N; Bridle RI
J Psychoactive Drugs; 2015; 47(2):140-8. PubMed ID: 25950594
[TBL] [Abstract][Full Text] [Related]
14. Knowledge and Use of Novel Psychoactive Substances in an Italian Sample with Substance Use Disorders.
Dal Farra D; Valdesalici A; Zecchinato G; De Sandre A; Saccon D; Simonato P; Corazza O; Martinotti G; Smith AL; Solmi M
Int J Environ Res Public Health; 2022 Jan; 19(2):. PubMed ID: 35055743
[TBL] [Abstract][Full Text] [Related]
15. Motivations for new psychoactive substance use among regular psychostimulant users in Australia.
Sutherland R; Bruno R; Peacock A; Lenton S; Matthews A; Salom C; Dietze P; Butler K; Burns L; Barratt MJ
Int J Drug Policy; 2017 May; 43():23-32. PubMed ID: 28161577
[TBL] [Abstract][Full Text] [Related]
16. How to ask about the use of new psychoactive substances to increase the validity of results in self-report prevalence surveys.
Drapalova E; Belackova V; Cadet-Taïrou A
Drug Alcohol Rev; 2020 Mar; 39(3):278-286. PubMed ID: 32078202
[TBL] [Abstract][Full Text] [Related]
17. Patterns and correlates of new psychoactive substance use in a sample of Australian high school students.
Champion KE; Teesson M; Newton NC
Drug Alcohol Rev; 2016 May; 35(3):338-44. PubMed ID: 26194894
[TBL] [Abstract][Full Text] [Related]
18. New psychoactive substances in Taiwan: The current situation and initiative for rational scheduling.
Yu WJ; Cottler L; Li JH
J Food Drug Anal; 2021 Mar; 29(1):168-181. PubMed ID: 35696229
[TBL] [Abstract][Full Text] [Related]
19. New Access Routes to Undertreated Populations; How Do Problem Substance Users Recruited from an Unemployment Office Differ from Detoxification Treatment Inpatients?
Scherbaum N; Mikoteit T; Witkowski L; Bonnet U; Specka M; Schifano F; Lieb B
Int J Environ Res Public Health; 2021 Dec; 18(24):. PubMed ID: 34948622
[TBL] [Abstract][Full Text] [Related]
20. [Bonzai, lead and bath salt-poisoning with new and old drugs : Synthetic amphetamines, cathinones, cannabinoids and opioids-an overview].
Strube J; Schaper A
Med Klin Intensivmed Notfmed; 2019 Nov; 114(8):684-692. PubMed ID: 29404633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
